Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

LUMO

Lumos Pharma (LUMO)

Lumos Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LUMO
FechaHoraFuenteTítuloSímboloCompañía
07/06/202415:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
05/06/202415:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUMOLumos Pharma Inc
04/06/202408:00GlobeNewswire Inc.Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024NASDAQ:LUMOLumos Pharma Inc
20/05/202415:05GlobeNewswire Inc.Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024NASDAQ:LUMOLumos Pharma Inc
14/05/202415:15GlobeNewswire Inc.Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial ResultsNASDAQ:LUMOLumos Pharma Inc
09/05/202413:51GlobeNewswire Inc.Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024NASDAQ:LUMOLumos Pharma Inc
18/04/202415:05GlobeNewswire Inc.Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical MeetingsNASDAQ:LUMOLumos Pharma Inc
20/03/202407:00GlobeNewswire Inc.Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042NASDAQ:LUMOLumos Pharma Inc
07/03/202415:48Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUMOLumos Pharma Inc
07/03/202415:01GlobeNewswire Inc.Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development UpdateNASDAQ:LUMOLumos Pharma Inc
26/02/202408:00GlobeNewswire Inc.Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024NASDAQ:LUMOLumos Pharma Inc
06/02/202415:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUMOLumos Pharma Inc
05/02/202415:05GlobeNewswire Inc.Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences ConferenceNASDAQ:LUMOLumos Pharma Inc
10/01/202418:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
04/01/202415:05GlobeNewswire Inc.Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical OfficerNASDAQ:LUMOLumos Pharma Inc
29/11/202315:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LUMOLumos Pharma Inc
21/11/202315:15GlobeNewswire Inc.Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone DeficiencyNASDAQ:LUMOLumos Pharma Inc
20/11/202315:05GlobeNewswire Inc.Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in NovemberNASDAQ:LUMOLumos Pharma Inc
07/11/202317:24Dow Jones NewsLumos Pharma Shares Than Double After Hormone Deficiency Trial Meets All EndpointsNASDAQ:LUMOLumos Pharma Inc
07/11/202316:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUMOLumos Pharma Inc
07/11/202315:35GlobeNewswire Inc.Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development UpdatesNASDAQ:LUMOLumos Pharma Inc
07/11/202315:01GlobeNewswire Inc.Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary EndpointsNASDAQ:LUMOLumos Pharma Inc
26/09/202308:00GlobeNewswire Inc.Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual MeetingNASDAQ:LUMOLumos Pharma Inc
14/09/202307:00GlobeNewswire Inc.Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual MeetingNASDAQ:LUMOLumos Pharma Inc
07/09/202315:34GlobeNewswire Inc.Lumos Pharma Announces Participation in Investor Conferences in SeptemberNASDAQ:LUMOLumos Pharma Inc
22/08/202308:00GlobeNewswire Inc.Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic LandscapeNASDAQ:LUMOLumos Pharma Inc
09/08/202315:01GlobeNewswire Inc.Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical UpdateNASDAQ:LUMOLumos Pharma Inc
26/07/202308:00GlobeNewswire Inc.Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023NASDAQ:LUMOLumos Pharma Inc
12/07/202307:00GlobeNewswire Inc.Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences SummitNASDAQ:LUMOLumos Pharma Inc
28/06/202315:01GlobeNewswire Inc.Lumos Pharma Announces Departure of Chief Medical OfficerNASDAQ:LUMOLumos Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:LUMO